Day One Biopharmaceuticals Inc Asset Turnover Ratio (DAWN), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Day One Biopharmaceuticals Inc   (NASDAQ: DAWN)
 

Day One Biopharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Day One Biopharmaceuticals Inc asset turnover ratio, the ability of Day One Biopharmaceuticals Inc 's assets to generate revenue in the fourth quarter 2025, increased sequentially to 0.31 in the fourth quarter (Dec 31 2025), yet the ratio remained below the average, as DAWN's position remain challenging.

Within sector 67 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the IV Quarter 2025, to 1863, from total ranking in the third quarter 2025 at 2424.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DAWN Asset Turnover Ratio (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Asset Change -12.92 % -14.56 % 29.04 % 62.95 % 54.53 %
Y / Y Revenue Change 83.92 % -57.56 % 313.92 % - -
Asset Turnover Ratio (TTM) 0.31 0.25 0.34 0.31 0.28
DAWN's Total Ranking # 1863 # 2424 # 2088 # 2469 # 0
Seq. Asset Change -1.13 % -1.03 % -2.86 % -8.39 % -2.99 %
Seq. Revenue Change 34.99 % 17.36 % 10.23 % 5.32 % -68.85 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 68
Healthcare Sector # 206
Overall Market # 1863

Asset Turnover Ratio Statistics
High Average Low
13.02 10.27 7.8
(Mar 31 2025)   (Dec 31 2025)




DAWN Company Profile • Back to DAWN Efficiency Comparisons • Compare DAWN Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Amneal Pharmaceuticals Inc   0.86 $ 3,018.308  Millions$ 3,516.548  Millions
Apyx Medical Corp  0.86 $ 52.044  Millions$ 60.638  Millions
Atricure Inc   0.85 $ 531.942  Millions$ 622.525  Millions
Caredx Inc   0.85 $ 379.805  Millions$ 444.858  Millions
Yunhong Green Cti Ltd   0.85 $ 19.590  Millions$ 22.991  Millions
Carlisle Companies Incorporated  0.85 $ 5,019.900  Millions$ 5,922.475  Millions
Fennec Pharmaceuticals Inc   0.85 $ 44.642  Millions$ 52.773  Millions
Verrica Pharmaceuticals Inc   0.84 $ 35.577  Millions$ 42.328  Millions
Teladoc Health Inc   0.84 $ 2,529.977  Millions$ 3,018.824  Millions
Eton Pharmaceuticals Inc   0.83 $ 79.740  Millions$ 95.583  Millions
Xeris Biopharma Holdings Inc   0.83 $ 291.845  Millions$ 350.964  Millions
Bionexus Gene Lab Corp   0.83 $ 7.425  Millions$ 8.944  Millions
Exelixis Inc   0.83 $ 2,320.126  Millions$ 2,795.824  Millions
Madrigal Pharmaceuticals Inc   0.83 $ 958.403  Millions$ 1,158.514  Millions
Incyte Corporation  0.83 $ 5,141.242  Millions$ 6,214.762  Millions
Penumbra Inc  0.82 $ 1,403.665  Millions$ 1,709.751  Millions
Insulet Corporation  0.82 $ 2,708.100  Millions$ 3,301.550  Millions
Lensar Inc   0.82 $ 58.435  Millions$ 71.252  Millions
Acadia Pharmaceuticals Inc   0.82 $ 1,071.505  Millions$ 1,313.221  Millions
Bioventus Inc   0.81 $ 566.845  Millions$ 695.839  Millions
Ironwood Pharmaceuticals inc   0.81 $ 296.151  Millions$ 365.781  Millions
Cadre Holdings inc   0.81 $ 609.628  Millions$ 753.204  Millions
Casi Pharmaceuticals inc   0.81 $ 20.712  Millions$ 25.650  Millions
Cue Biopharma Inc   0.80 $ 27.466  Millions$ 34.204  Millions
Alnylam Pharmaceuticals Inc   0.80 $ 3,713.937  Millions$ 4,649.456  Millions
Alpha Pro Tech Ltd   0.80 $ 58.537  Millions$ 73.337  Millions
Airsculpt Technologies Inc   0.78 $ 151.818  Millions$ 193.713  Millions
Davita Inc   0.78 $ 13,643.069  Millions$ 17,411.996  Millions
Iradimed Corporation  0.78 $ 83.814  Millions$ 107.919  Millions
Labcorp Holdings Inc   0.77 $ 13,951.700  Millions$ 18,079.500  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.